本页面由Tiger Trade Technology Pte. Ltd.提供服务

Portola Pharmaceuticals Inc.

18.03
0.0000
成交量:- -
成交额:- -
市值:14.16亿
市盈率:-4.76
高:18.03
开:18.03
低:18.03
收:18.03
52周最高:31.73
52周最低:5.31
股本:7,851.73万
流通股本:7,322.61万
量比:- -
换手率:- -
股息:- -
股息率:- -
每股收益(TTM):-3.7842
每股收益(LYR):-4.0621
净资产收益率:-462.25%
总资产收益率:-30.59%
市净率:19.65
市盈率(LYR):-4.44

数据加载中...

2020/07/02

员工持股计划

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2020/07/02

员工持股计划

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2020/07/02

员工持股计划

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2020/07/02

员工持股计划

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2020/07/02

交易所摘牌声明

25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
2020/07/02

员工持股计划

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2020/07/02

员工持股计划

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2020/07/02

员工持股计划

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2020/07/02

员工持股计划

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2020/07/02

员工持股计划

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2020/07/02

重要事件披露

8-K - Current report
2020/06/17

重要事件披露

8-K - Current report
2020/06/15

重要事件披露

8-K - Current report
2020/06/09

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2020/06/08

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2020/05/11

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/05/11

重要事件披露

Current report, items 2.02 and 9.01
2020/05/08

超过5%披露

General statement of acquisition of beneficial ownership
2020/05/07

重要事件披露

Current report, items 1.01, 5.03, and 9.01
2020/05/05

重要事件披露

Current report, items 8.01 and 9.01